Behavioral interventions for HIV-positive and HCV-positive drug users

AIDS and Behavior

Volumn 10, Issue 2, 2006, Pages 115-130

  Strathdee, Steffanie A ^a   Patterson, Thomas L ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hepatitis C virus; HIV AIDS; Homosexual men; Injection drug use; Intervention; Review

Indexed keywords

ANTIRETROVIRUS AGENT; BUPRENORPHINE; DIAMORPHINE; ILLICIT DRUG; METHADONE; MICROBICIDE; OPIATE; OPIATE AGONIST; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BEHAVIOR THERAPY; BODY BURDEN; DISEASE ASSOCIATION; DRUG ABUSE; EPIDEMIC; FREQUENCY ANALYSIS; HEALTH CARE COST; HEALTH PROGRAM; HEPATITIS C; HEPATITIS C VIRUS; HETEROSEXUALITY; HIGH RISK BEHAVIOR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INFORMATION RETRIEVAL; INJECTION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; MEDICAL INFORMATION; NONHUMAN; RELAPSE; REVIEW; RISK ASSESSMENT; SERODIAGNOSIS; SEXUALLY TRANSMITTED DISEASE; VIRUS TRANSMISSION;

ANTI-RETROVIRAL AGENTS; BEHAVIOR THERAPY; HEALTH PROMOTION; HEPATITIS C; HIV SEROPOSITIVITY; HOMOSEXUALITY, MALE; HUMANS; MALE; SOCIAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 33645841974     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-005-9055-5     Document Type: Review

References (137)

1. Alter, M. J., Kruszon-Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., Kaslow, R., and Margolis, H. S. (1999). The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. New England Journal of Medicine, 341, 556-562.
2. Altice, F. L., Mezger, J. A., Hodges, J., Bruce, R. D., Marinovich, A., Walton, M., Springer, S. A., and Friedland, G. H. (2004). Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: implications for program replication. Clinical Infectious Diseases, 38, S376-S387.
3. Auerbach, J. D., and Coates, T. J. (2000). HIV prevention research: accomplishments and challenges for the third decade of AIDS. American Journal of Public Health, 90, 29-32.
4. Ball, A. L. (2002). Overview: Policies and interventions to stem HIV-1 epidemics associated with injecting drug use. In G. Stimson, D. C. Des Jarlais, and A. Ball (Eds.), Drug Injecting and HIV Infection: Global Dimensions and Local Responses (pp. 201-232). London: UCL Press.
5. Ball, J. C., Lange, W. R., Myers, C. P., and Friedman, S. R. (1988). Reducing the risk of AIDS through methadone maintenance treatment. Journal of Health and Social Behavior, 29, 214-226.
6. Bastos, F. I., and Strathdee, S. A. (2000). Evaluating Effectiveness of Syringe Exchange Programmes: Current Issues and Future Prospects. Social Science & Medicine, 51, 1771-1782.
7. Beckett, M., Burnam, A., Collins, R. L., Kanouse, D. E., and Beckman, R. (2003). Substance use and high-risk sex among people with HIV: a comparison across exposure groups. AIDS and Behavior, 7, 209-219.
8. Benotsch, E. G., Kalichman, S., and Cage, M. (2002). Men who have met sex partners via the Internet: prevalence, predictors, and implications for HIV prevention. Archives of Sexual Behavior, 31, 177-183
9. Bluthenthal, R. N., Kral, A. H., Gee, L., Erringer, E. A., and Edlin, B. R. (2000). The effect of syringe exchange use on high-risk injection drug users: a cohort study. AIDS, 14, 605-611.
10. Booth, R. E., Crowley, and Zhang, Y. (1996). Substance abuse treatment entry, retention, and effectiveness: out-of-treatment opiate injection drug users. Drug and Alcohol Dependence, 42, 11-20
11. Brooks, J. S., Nomura, C., and Cohen, P. (1989). A network of influences on adolescent drug users involvement: Neighborhood, school, peer, and family. Genetic, Social, and General Psychology Monographs, 115, 125-145.
12. Brooner, R., Kidorf, M., King, V., Beilenson, P., Svikis, D., and Vlahov, D. (1998). Drug abuse treatment success among needle exchange participants. Public Health Reports, 113, 129-39.
13. Bruneau, J., Lamothe, F., Franco, E., Lachance, N., Desy, M., Soto, J., and Vincelette, J. (1997). High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study. American Journal of Epidemiology, 146, 994-1002.
14. Bull, S. S., Piper, P., and Rietmeijer, C. (2002). Men who have sex with men and also inject drugs-profiles of risk related to the synergy of sex and drug injection behaviors. Journal of Homosexuality, 42, 31-51.
15. Buning, E. C., Coutinho, R. A., van Brussel, G. H., van Santen, G. W., and van Zadelhoff, A. W. (1986). Preventing AIDS in drug addicts in Amsterdam. Lancet, 1, 1435.
16. Carrieri, M. P., Rey, D., Loundou, A., Lepeu, G., Sobel, A., Obadia, Y., and The MANIF-2000 Study Group (2003). Evaluation of buprenorphine maintenance treatment in a French cohort of HIV-infected injecting drug users. Drug and Alcohol Dependence, 72, 13-21.
17. Catania, J. A., Morin, S. F., Canchola, J., Pollack, L., Chang, J., and Coates, T. J. (2000). Health care policy. U.S. priorities-HIV prevention. Science, 290, 717.
18. Celentano, D. D., Galai, N., Sethi, A. K., Shah, N. G., Strathdee, S. A., Vlahov, D., and Gallant, J. E. (2001). Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. AIDS, 15, 1707-15.
19. Celentano, D. D., Vlahov, D., Cohn, S., Anthony, J. C., Solomon, L., and Nelson, K. E. (1991). Risk factors for shooting gallery use and cessation among intravenous drug users. American Journal of Public Health, 81, 1291-1295.
20. Celentano, D. D., Vlahov, D., Cohn, S., Shadle, V. M., Obasanjo, O., and Moore, R. D. (1998). Self-reported antiretroviral therapy in injection drug users. The Journal of the American Medical Association, 280, 544-6.
21. Centers for Disease Control and Prevention. (2004). High-Risk Sexual Behavior by HIV-Positive Men Who Have Sex with Men - 16 Sites, United States, 2000-2002. Morbidity and Mortality Weekly Report, 53, 891-894. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5338a1.htm.
22. Chiasson, M. A., Stoneburner, R. L., Hildebrandt, D. S., Ewing, W. E., Telzak, E. E., and Jaffe, H. W. (1991). Heterosexual transmission of HIV-1 associated with the use of smokeable freebase cocaine (crack). AIDS, 9, 1121-1126.
23. Chng, C. L., and Geliga-Vargas, J. (2000). Ethnic identity, gay identity, sexual sensation seeking and HIV risk taking among multiethnic men who have sex with men. AIDS Education and Prevention, 12, 326-339.
24. Chu, P. L., McFarland, W., Gibson, S., Weide, D., Henne, J., Miller, P., Partridge, T., and Schwarcz, S. (2003). Viagra use in a community-recruited sample of men who have sex with men, San Francisco. Journal of Acquired Immune Deficiency Syndrome, 33, 191-3.
25. Cleary, P. D., Van Devanter, N., Steilen, M., Stuart, A., Shipton-Levy, R., McMullen, W., Rogers, T. F., Singer, E., Avorn, J., and Pindyck, J. (1995). A randomized trial of an education and support program for HIV-infected individuals. AIDS, 9, 1271-1278.
26. Conway, B., Prasad, J., Reynolds, R. et. al. (2004). Directly Observed Therapy for the Management of HIV Infected Patients in a Methadone Program. Clinical Infectious Diseases, 38, S402-S408.
27. Copenhaver, M., Avants, S. K., Warburton, L. A., and Margolin, A. (2003). Intervening effectively with drug abusers infected with HIV: taking into account the potential for cognitive impairment. Journal of Psychoactive Drugs, 35, 209-18.
28. Crawford, I., Hammack, P. L., McKirnan, D. J., Ostrow, D., Zamboni, B. D., Robinson, B., and Hope, B. (2003). Sexual sensation seeking, reduced concern about HIV and sexual risk behaviour among gay men in primary relationships. AIDS Care, 15, 513-24.
29. Crofts, N., Nigro, L., Oman, K., Stevenson, E., and Sherman, J. (1997). Methadone maintenance and hepatitis C virus infection among injecting drug users. Addiction, 92, 999-1005.
30. Cross, J. E., Saunders, C. M., and Bartelli, D. (1998). The effectiveness of educational and needle exchange programs: a meta-analysis of HIV prevention strategies for injecting drug users. Quality and Quantity, 32, 165-180.
31. Deren, S., Beardsley, M., Tortu, S., and Goldstein, M. F. (1998). HIV serostatus and changes in risk behaviors among drug injectors and crack users. AIDS and Behavior, 2, 171-176.
32. Des Jarlais, D. C. (1989). AIDS prevention programs for intravenous drug users: Diversity and evolutions. International Review of Psychiatry, 1, 101-108.
33. Des Jarlais, D. C., Hagan, H., Friedman, S. R., Friedmann, P., Goldberg, D., Frischer, M., Green, S., Tunving, K., Ljungberg, B., Wodak, A., et al. (1995). Maintaining low HIV seroprevalence in populations of injecting drug users. The Journal of the American Medical Association, 274, 1226-1231.
34. Des Jarlais, D. C., Marmor, M., Friedmann, P., Titus, S., Aviles, E., Deren, S., Torian, L., Glebatis, D., Murrill, C., Monterroso, E., and Friedman, S. R. (2000). HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic. American Journal of Public Health, 90, 352-359.
35. Des Jarlais, D. C., Perlis, T., Arasteh, K., Hagan, H., Milliken, J., Braine, N., Yancovitz, S., Mildvan, D., Perlman, D. C., Maslow, C., and Friedman, S. R. (2004). Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001. Journal of Acquired Immune Deficiency Syndromes, 35, 158-166.
36. Diamond, C., Thiede, H., Perdue, T., Secura, G. M., Valleroy, L., Mackellar, D., Corey, L. and Seattle Young Men's Survey Team. (2003). Viral hepatitis among young men who have sex with men: prevalence of infection, risk behaviors, and vaccination. Sexually Transmitted Diseases, 30, 425-32.
37. DiScenza, S., Nies, M., and Jordan, C. (1996). Effectiveness of counseling in the health promotion of HIV-positive clients in the community. Public Health Nursing, 13, 209-216.
38. Dolezal, C., Carballo-Dieguez, A., Nieves-Rosa, L., and Diaz, F. (2000). Substance use and sexual risk behavior: understanding their association among four ethnic groups of Latino men who have sex with men. Journal of Substance Abuse, 11, 323-36.
39. Drucker, E., Lurie, P., Wodak, A., and Alcabes, P. (1998). Measuring harm reduction: the effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV. AIDS, 12, S217-S230.
40. Edlin, B. R., Irwin, K. L., Faruque, S., McCoy, C. B., Word, C., Serrano, Y., Inciardi, J. A., Bowser, B. P., Schilling, R. F., and Holmberg, S. D. (1994). Intersecting epidemics - crack cocaine use and HIV infection among inner-city young adults. New England Journal of Medicine, 331, 1422-1427.
41. Elliot, D. S., Huizinga, D., and Ageton, S. S. (1985). Explaining delinquency and drug use. Beverly Hills, CA: Sage.
42. Fisher, J. D., and Fisher, W. A. (1992). Changing AIDS risk behavior. Psychological Bulletin, 111, 455-474.
43. Fisher, J. D., and Misovich, S. J. (1990). Social influence and AIDS-preventive behaviors. In J. Edwards, R. Tindale, L. Heath, and E. Posavac (Eds.), Applying social influence processes in preventing social problems (pp. 39-70). New York: Plenum Press.
44. Friedman, S. R., Des Jarlais, D. C., Sotheran, J. L., Garber, J., Cohen, H., and Smith, D. (1987). AIDS and self- organization among intravenous drug users. The International Journal of the Addictions, 23, 201-219.
45. Friedman, S. R., Jose, B., Neaigus, A., Goldstein, M., Curtis, R., Ildefonso, G., Mota, P., and Des Jarlais, D. C. (1994). Consistent condom use in relationships between seropositive injecting drug users and sex partners who do not inject drugs. AIDS, 8, 357-61.
46. Galvan, F. H., Burnam, M. A., and Bing, E. G. (2003). Co-occurring psychiatric symptoms and drug dependence or heavy drinking among HIV-positive people. Journal of Psychoactive Drugs, 35, 153-60.
47. Garfein, R. S., Doherty, M. C., Monterroso, E. R., Thomas, D. L., Nelson, K. E., and Vlahov, D. (1998). Prevalence and incidence of hepatitis C virus infection among young adults injection drug users. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 8, S11-S19.
48. Garfein, R. S., Vlahov, D., Galai, N., Doherty, M. C., and Nelson, K. E. (1996). Viral infections in short-term injection drug users; the prevalence of the hepatitis C, hepatitis B, human immunodeficiency virus, and human T-lymphotropic virus. American Journal of Public Health, 86, 655-661.
49. Gerberding, J. (1995). Management of occupational exposure to blood borne viruses. New England Journal of Medicine, 332, 444-451.
50. Gordon, C. M., Stall, R., and Cheever, L. W. (2004). Prevention interventions with persons living with HIV/AIDS: Challenges, Progress, and Research Priorities. Journal of acquired immune deficiency syndromes, 37, S53-S57.
51. Greenblatt, J. C., and Gfoerer, J. C. (1996). Methamphetamine abuse in the United States. Analysis of Substance Abuse and Treatment Need Issues. Rockville, MD: Substance Abuse and Mental Health Services Administration.
52. Hagan, H., and Des Jarlais, D. C. (2000). HIV and HCV infection among injecting drug users. The Mount Sinai Journal of Medicine, 67, 423-8.
53. Hagan, H., DesJarlais, D. C., Friedman, S. R., Purchase, D., and Alter, M. J. (1995). Reduced risk of Hepatitis B and Hepatitis C among injection drug users in the Tacoma Syringe Exchange Program. American Journal of Public Health, 1531-1537.
54. Hahn, J. A., Vranizan, K. M., and Moss, A. R. (1997). Who uses needle exchange? A study of injection drug users in treatment in San Francisco, 1989-1990. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 15, 157-64.
55. Halkitis, P. N., Parsons, J. T., and Wilton, L. (2003). Barebacking among gay and bisexual men in New York City: explanations for the emergence of intentional unsafe behavior. Archives of Sexual Behavior, 32, 351-7.
56. Heimer, R. (1998). Can syringe exchange serve as a conduit to substance abuse treatment? Journal of Substance Abuse Treatment, 15, 183-91.
57. Heimer, R., Khoshnood, K., Bigg, D., Guydish, J., and Jungue, B. (1998). Syringe use and reuse: effects of syringe exchange programs in four cities. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18, S37.
58. Holmberg, S. D. (1996). The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. American Journal of Public Health, 86, 643-654.
59. Hubbard, R. L., Marsden, M. E., Cavanaugh, E., Rachal, J. V., and Ginzburg, H. M. (1988). Role of drug-abuse treatment in limiting the spread of AIDS. Reviews of Infectious Diseases, 10, 377-84.
60. Janssen, R. S., Holtgrave, D. R., Valdiserri, R. O., Shepherd, M., Gayle, H. D., and De Cock, K. M.(2001). The Serostatus Approach to Fighting the HIV Epidemic: prevention strategies for infected individuals. American Journal of Public Health, 91, 1019-1024.
61. Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L., and Bigelow, G. E. (2000). A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. New England Journal of Medicine, 343, 1290-1297.
62. Johnson, W. D., Hedges, L. V., Ramirez, G., Semaan, S., Norman, L. R., Sogolow, E., Sweat, M. D., and Diaz, R. M. (2002). HIV prevention research for men who have sex with men: A systematic review and meta-analysis. Journal of Acquired Immune Deficiency Syndromes, 30, S118-S129.
63. Kalichman, S. C., Heckman, T., and Kelly, J. A. (1996). Sensation seeking as an explanation for the association between substance use and HIV-related risky sexual behavior. Archives of Sexual Behavior, 25, 141-54.
64. Kalichman, S. C., Kelly, J. A., and Rompa, D. (1997). Continued high-risk sex among HIV seropositive gay and bisexual men seeking HIV prevention services. Health Psychology, 16, 369-373.
65. Kalichman, S. C., Rompa, D., Cage, M., DiFonzo, K., Simpson, D., Austin, J., Luke, W., Buckles, J., Kyomugisha, F., Benotsch, E., Pinkerton, S., and Graham, J. (2001). Effectiveness of an intervention to reduce HIV transmission risks in HIV-positive people. American Journal of Preventive Medicine, 21, 84-92.
66. Kalichman, S. C., Weinhardt, L., DiFonzo, K., Austin, J., and Luke, W. (2002). Sensation seeking and alcohol use as markers of sexual transmission risk behavior in HIV-positive men. Annals of Behavioral Medicine, 24, 229-35.
67. Kim, A. A., Kent, C., McFarland, W., and Klausner, J. D. (2001). Cruising on the Internet highway. Journal of Acquired Immune Deficiency Syndrome, 28, 89-93.
68. Kosten, T., Oliveto, A., Feingold, A., Poling, J., Sevarino, K., McCance-Katz, E., Stine, S., Gonzalez, G., and Gonsai, K. (2003). Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients. Drug and Alcohol Dependence, 70, 315-325
69. Kral, A. H., Bluthenthal, R. N., Lorvick, J., Gee, L., Bacchetti, P., and Edlin, B. R. (2001). Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet, 357, 1397-1401.
70. Langendam, M. W., van Brussel, G. H., Coutinho, R. A., and van Ameijden, E. J. (1999). Methadone maintenance treatment modalities in relation to incidence of HIV: results of the Amsterdam cohort study. AIDS, 13, 1711-1716.
71. Latkin, C. A., Forman, V., Knowlton, A., Hoover, D., Hatcher, M., and Celentano, D. D. (2001). Injection Drug Users' Disclosure of HIV Seropositive Status to Network Members. AIDS and Behavior, 5, 297-305.
72. Latkin, C. A., Forman-Hoffman, V. L., D'Souza, G., and Knowlton, A. R. (2004). Associations between medical service use and HIV risk among HIV-positive drug users in Baltimore, MD. AIDS Care, 16, 901-908.
73. Latkin, C. A., Sherman, S. G., and Knowlton, A. (2003). HIV prevention among drug users: Outcome of a network-oriented peer outreach intervention. Health Psychology, 22, 332-339.
74. Lau, J. T., Kim, J. H., Lau, M., and Tsui, H. Y. (2003). Prevalence and risk behaviors of Chinese men who seek same-sex partners via the internet in Hong Kong. AIDS Education and Prevention, 15, 516-28.
75. Leigh, B. C. (2002). Alcohol and condom use: a meta-analysis of event-level studies. Sexually Transmitted Diseases, 29, 476-82.
76. Loughlin, A., and Strathdee, S. A. (In Press). Hepatitis C infection among drug users enrolled in methadone maintenance program. The International Journal on Drug Policy.
77. Lucas, G. M., Cheever, L. W., Chaisson, R. E., and Moore, R. D. (2001). Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes, 27, 251-259.
78. Lucas, G. M., Weidle, P. J., Hader, S., Moore, R. D. (2004). Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a nonrandomized comparative study. Clinical Infectious Diseases, 38, S409-S413.
79. Lurie, P., Gorsky, R., Jones, T. S., and Shomphe, L. (1998). An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18, S126-S132.
80. Macalino, G. E., Mitty, J. A., Bazerman, L. B., Singh, K., McKenzie, M., and Flanigan, T. (2004). Modified directly observed therapy for the treatment of HIV-seropositive substance users: lessons learned from a pilot study. Clinical Infectious Diseases, 38, S393-S397.
81. MacGowan, R. J., Brackbill, R. M., Rugg, D. L., Swanson, N. M., Weinstein, B., Couchon, A., Scibak, J., Molde, S., McLaughlin, P., Barker, T., and Voigt, R. (1997). Sex, drugs and HIV counseling and testing: a prospective study of behavior-change among methadone-maintenance clients in New England. AIDS, 11, 229-35.
82. Marmor, M., Friedman-Kien, A. E., Laubenstein, L., Byrum, R. D., William, D. C., D'Onofrio, S., and Dubin, N. (1982). Risk factors for Kaposi's sarcoma in homosexual men. Lancet, 15, 1083-7.
83. Mattison, A. M., Ross, M. W., Wolfson, T., Franklin, D., and the HIV Neurobehavioral Research Center Group (2001). Circuit party attendance, club drug use, and unsafe sex in gay men. Journal of Substance Abuse, 13, 119-26.
84. McCance-Katz, E. F., Rainey, P. M., Friedland, G., and Jatlow, P. (2003). The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients. Clinical Infectious Diseases, 37, 476-82.
85. McCance-Katz, E. F., Rainey, P. M., Jatlow, P., and Friedland, G. (1998). Methadone effects on zidovudine disposition (AIDS Clinical Trials Group 262). Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18, 435-43.
86. McCusker, J., Stoddard, A. M., Hindin, R. N., Garfield, F. B., and Frost, R. (1996). Changes in HIV risk behavior following alternative residential programs of drug abuse treatment and AIDS education. Annals of Epidemiology, 6, 119-125.
87. McMahon, R. C., Malow, R. M., Jennings, T. E., and Gomez, C. J. (2001). Effects of a cognitive-behavioral HIV prevention intervention among HIV negative male substance abusers in VA residential treatment. AIDS Education and Prevention, 13, 91-107.
88. Meandzija, B., O'Connor, P. G., Fitzgerald, B., Rounsaville, B. J., and Kosten, T. R. (1994). HIV infection and cocaine use in methadone maintained and untreated intravenous drug users. Drug and Alcohol Dependence, 36, 109-13.
89. Metsch, L. R., McCoy, C. B., Lai, S., and Miles, C. (1998). Continuing risk behaviors among HIV-seropositive chronic drug users in Miami, Florida. AIDS and Behavior, 2, 161-169.
90. Metsch, L. R., Pereyra, M., and Brewer, T. H. (2001). Use of HIV health care in HIV-seropositive crack cocaine smokers and other active drug users. Journal of Substance Abuse, 13, 155-67.
91. Metzger, D. S., and Navaline, H. (2003). Human immunodeficiency virus prevention and the potential of drug abuse treatment. Clinical Infectious Diseases, 37, S451-S456.
92. Metzger, D. S., Woody, G. E., McLellan, A. T., O'Brien, C. P., Druley, P., Navaline, H., DePhilippis, D., Stolley, P., Abrutyn, E. (1993). Human immunodeficiency virus seroconversion among in- and out-of-treatment intravenous drug users: an 18-month prospective follow-up. Journal of Acquired Immune Deficiency Syndromes, 6, 1049-1056.
93. National Commission on AIDS. (1991). The twin epidemics of substance abuse and HIV. Washington, DC: National Commission on AIDS.
94. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. (1998). Effective medical treatment of opiate addiction. Journal of the American Medical Association, 280, 1936-1943.
95. NIH Consensus Statement. (1997). Interventions to prevent HIV risk behaviors. 15, 1-41
96. Normand, J., Vlahov, D., and Moses, L. E. (1995). Preventing HIV transmission: the role of sterile needles and bleach. Washington, DC: National Academy Press.
97. Office of the Surgeon General. (2000). Evidence-based findings on the efficacy of syringe exchange programs: an analysis from the Assistant Secretary for Health and Surgeon General of the scientific research completed since April 1998. Washington, DC: Office of the Surgeon General. http://www.harmreduction.org/surgreview.html.
98. Ompad, D. C., Fuller, C. M., Vlahov, D., Thomas, D., and Strathdee, S. A. (2002). Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland. Clinical Infectious Diseases, 35, 783-788.
99. Ostrow, D. E., Fox, K. J., Chmiel, J. S., Silvestre, A., Visscher, B. R., Vanable, P. A., Jacobson, L. P., and Strathdee, S. A. (2002). Attitudes towards highly active antiretroviral therapy are associated with sexual risk taking among HIV-infected and uninfected homosexual men. AIDS, 16, 775-780.
100. Palepu, A., Tyndall, M. W., Li, K., Yip, B., O'Shaughnessy, M. V., Schechter, M. T., Montaner, J. S., and Hogg, R. S. (2003). Alcohol Use and Incarceration Adversely Affect HIV-1 RNA Suppression Among Injection Drug Users Starting Antiretroviral Therapy. Journal of Urban Health, 80, 667-75.
101. Parsons, J. T., and Halkitis, P. N. (2002). Sexual and drug-using practices of HIV-positive men who frequent public and commercial sex environments. AIDS Care, 14, 815-26.
102. Parsons, J. T., Huszti, H. C., Crudder, S. O., Rich, L., and Mendoza, J. (2000). Maintenance of safer sexual behaviours: Evaluation of a theory-based intervention for HIV seropositive men with hemophilia and their female partners. Hemophilia, 6, 181-197.
103. Patterson, T. L., and Semple, S. J. (2002). Reducing the Sexual Risk Behaviors of HIV-positive Individuals: Outcome of a Randomized Controlled Trial. Annals of Behavioral Medicine, 25.
104. Prendergast, M. L., Urada, D., and Podus, D. J. (2001). Meta-analysis of HIV risk-reduction interventions within drug abuse treatment programs. Journal of Consulting and Clinical Psychology, 69, 389-405.
105. Purcell, D. W., Metsch, L. R., Latka, M., Santibanez, S., and Gomez, C. A., Eldred, L., and Latkin, C. A. (2004). Interventions for seropositive injectors - Research and evaluation - An integrated behavioral intervention with HIV-positive injection drug users to address medical care, adherence, and risk reduction. Journal of Acquired Immune Deficiency Syndromes, 37, S110-S118.
106. Rhodes, T., and Hartnoll, R. (1996). AIDS, Drugs, and Prevention: Perspectives on Individual and Community Action. London: Routledge.
107. Rippeth, J. D., Heaton, R. K., Carey, C. L., Marcotte, T. D., Moore, D. J., Gonzalez, R., Wolfson, T., Grant, I., and the HNRC group. (2004). Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. Journal of the International Neuropsychological Society, 10, 1-14.
108. Robles, R. R., Marrero, C. A., Reyes, J. C., Colon, H. M., Matos, T. D., Finlinson, H. A., Munoz, A., Melendez, M., and Sahai, H. (1998). Risk behaviors, HIV seropositivity, and tuberculosis infection in injecting drug users who operate shooting galleries in Puerto Rico. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 17, 477-83.
109. Ross, M. W., Mattison, A. M., and Franklin, D. R. (2003). Club drugs and sex on drugs are associated with different motivations for gay circuit party attendance in men. Substance Use & Misuse, 38, 1173-83.
110. Schechter, M. T., Strathdee, S. A., Cornelisse, P. G., Currie, S., Patrick, D. M., Rekart, M. L., and O'Shaughnessy, M. V. (1999). Do needle exchange programmes increase the spread of HIV among injection drug users?: An investigation of the Vancouver outbreak. AIDS, 13, F45-F51
111. Semaan, S., Des Jarlais, D. C., Sogolow, E., Johnson, W. D., Hedges, L. V., Ramirez, G., Flores, S. A., Norman, L., Sweat, M. D., and Needle, R. (2002). A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States. Journal of Acquired Immune Deficiency Syndromes, 30, S73-S93.
112. Semple, S. J., Patterson, T. L., and Grant, I. (2003). Binge Use of Methamphetamine Among HIV-positive Men Who Have Sex With Men: Pilot Data And HIV Prevention Implications. AIDS Education and Prevention, 15, 133-147
113. Shah, N., Celentano, D. D., Vlahov, D., Stambolis, V., Johnson, L., Nelson, K. E., and Strathdee, S. A. (2000). Correlates of enrollment in methadone maintenance programs differ by HIV-serostatus. AIDS, 14, 2035-43.
114. Stimson, G. V., and Choopanya, K. (1998). Global Perspectives on Drug Injecting. In G. V. Stimson, D. C. Des Jarlais, A. Ball (Eds.), Drug Injecting and HIV Infection: Global Dimensions and Local Responses (Social Aspects of AIDS) (pp.1-21). London: UCL Press.
115. Strathdee, S. A., Celentano, D. D., Shah, N., Lyles, C., Macalino, G., Nelson, K., and Vlahov, D. (1999). Needle Exchange Attendance and Health Care Utilization Promote Entry into Detoxification. Journal of Urban Health, 76, 448-460.
116. Strathdee, S. A., Galai, N., Safaiean, M., Celentano, D. D., Vlahov, D., Johnson, L., and Nelson, K. E. (2001). Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective. Archives of Internal Medicine, 161, 1281-8.
117. Strathdee, S. A., Palepu, A., Cornelisse, P. G. A., Yip, B., O'Shaughnessy, M. V., Montaner, J. S. T., Schechter, M. T., and Hogg, R. S. (1998). Barriers to utilization of antiretroviral therapies among HIV-infected injection drug users in a universal health care setting. Journal of American Medical Association, 280, 547-549.
118. Strathdee, S. A., Patrick, D. M., Archibald, C. P., Ofner, M., Cornelisse, P. G. A., Rekart, M. L., Schechter, M. T., and O'Shaughnessy, M. V. (1997). Social determinants predict needle sharing behaviour among injection drug users in Vancouver, Canada. Addiction, 92, 1339-1347.
119. Strauss, S. M., Des Jarlais, D. C., Astone, J., and Vassilev, Z. P. (2003). On-site HIV testing in residential drug treatment units: results of a nationwide survey. Public Health Reports, 118, 37-43.
120. Sylvestre, D. L. (2002). Treating hepatitis C in methadone maintenance patients: an interim analysis. Drug and Alcohol Dependence, 67, 117-123.
121. Sylvestre, D. L., Loftis, J. M., Hauser, P., Genser, S., Cesari, H., Borek, N., Kresina, T. F., Seeff, L., and Francis, H. (2004). Co-occurring Hepatitis C, substance use, and psychiatric illness: treatment issues and developing integrated models of care. Journal of Urban Health, 81, 719-34.
122. Thomas, D. L., Astemborski, J., Rai, R. M., Anania, F. A., Schaeffer, M., Galai, N., Nolt, K., Nelson, K. E., Strathdee, S. A., Johnson, L., Laeyendecker, O., Boitnott, J., Wilson, L. E., and Vlahov, D. (2000). The natural history of Hepatitis C virus infection: host, viral, and environmental factors. Journal of American Medical Association, 284, 450-456.
123. Tun, W., Celentano, D. D., Vlahov, D., and Strathdee, S. A. (2003). Attitudes toward HIV treatments influence unsafe sexual and injection practices among injecting drug users. AIDS, 17, 1953-1962.
124. Tyndall, M. W., Currie, S., Spittal, P., Li, K., Wood, E., O'Shaughnessy, M. V., and Schechter, M. T. (2003). Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS, 17, 887-93.
125. U.S. General Accounting Office. (1993). Needle exchange programs: research suggests promise as an AIDS prevention strategy. Washington, DC: US Government Printing Office. (Publication no. GAO/HRD 93-60).
126. Valleroy, L. A., MacKellar, D. A., Karon, J. M., Rosen, D. H., McFarland, W., Shehan, D. A., Stoyanoff, S. R., LaLota, M., Celentano, D. D., Koblin, B. A., Thiede, H., Katz, M. H., Torian, L. V., and Janssen, R. S. (2000). HIV prevalence and associated risks in young men who have sex with men. Young Men's Survey Study Group. Journal of American Medical Association, 284, 198-204.
127. van Ameijden, E. J., and Coutinho, R. A. (2001). Large decline in injecting drug use in Amsterdam, 1986-1998: explanatory mechanisms and determinants of injecting transitions. Journal of Epidemiology and Community Health, 55, 356-363
128. van Beek, I., Dwyer, R., Dore, G. J., Luo, K., and Kaldor, J. M. (1998). Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study. British Medical Journal, 317, 433-437.
129. van Empelen, P., Kok, G., van Kesteren, N. M., van den Borne, B., Bos, A. E., and Schaalma, H. P. (2003). Effective methods to change sex-risk among drug users: a review of psychosocial interventions. Social Science & Medicine, 57, 1593-608.
130. Vastag, B. (2001). Ecstasy experts want realistic messages. Journal of the American Medical Association, 286, 777.
131. Vertefeuille, J., Marx, M. A., Tun, W., Huettner, S., Strathdee, S. A., and Vlahov, D. (2000). Decline in Self-Reported High Risk Injection-Related Behaviors Among HIV Seropositive Participants in the Baltimore Needle Exchange Program. AIDS and Behavior, 4, 381-388.
132. Vlahov, D., Junge, B., Brookmeyer, R., Cohn, S., Riley, E., Armenian, H., and Beilenson, P. (1997). Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology, 16, 400-406.
133. Warner, B. D., and Leukefeld, C. G. (2001). Assessing the differential impact of an HIV prevention intervention: who's putting the message into practice? AIDS Education and Prevention, 13, 479-94.
134. Weinhardt, L. S., Otto-Salaj, L. L., Brondino, M. J., Norberg, M. M., and Kalichman, S. C. (2002). Sex-related alcohol expectancies predict sexual risk behavior among severely and persistently mentally ill adults. Psychology of Addictive Behaviors, 16, 64-7.
135. Wolitski, R. J., Gomez, C. A., and Parsons, J. T. (2005a). Effects of a peer-led behavioral intervention to reduce HIV transmission and promote serostatus disclosure among HIV-seropositive gay and bisexual men. AIDS, 19, Suppl 1, S99-109.
136. Wolitski, R. J., Parsons, J. T., Gomez, C. A. Purcell, D. W., Hoff, C. C., and Halkitis, P. N. (2005b). Prevention with gay and bisexual men living with HIV: rationale and methods of the Seropositive Urban Men's Intervention Trial (SUMIT). AIDS, 19 Suppl 1, S1-11.
137. Woody, G. E., Donnell, D., Seage, G. R., Metzger, D., Marmor, M., Koblin, B. A., Buchbinder, S., Gross, M., Stone, B., and Judson, F. N. (1999). Non-injection substance use correlates with risky sex among men having sex with men: data from HIVNET. Drug & Alcohol Dependence, 53, 197-205.